Canada Pension Plan Investment Board
SGTX

Canada Pension Plan Investment Board’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio SGTX Stock Details SGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-114,244
Closed -$2.57M – 1115
2023
Q2 		$2.57M Sell
114,244
-1
-0% -$7 ﹤0.01% 684
2023
Q1 		$1.38M Hold
114,245
– – ﹤0.01% 839
2022
Q4 		$520K Hold
114,245
– – ﹤0.01% 924
2022
Q3 		$750K Hold
114,245
– – ﹤0.01% 921
2022
Q2 		$1.23M Hold
114,245
– – ﹤0.01% 765
2022
Q1 		$2.18M Hold
114,245
– – ﹤0.01% 725
2021
Q4 		$4.1M Hold
114,245
– – ﹤0.01% 743
2021
Q3 		$8.39M Hold
114,245
– – 0.01% 607
2021
Q2 		$15.9M Hold
114,245
– – 0.02% 458
2021
Q1 		$33.2M Hold
114,245
– – 0.04% 336
2020
Q4 		$71.3M Buy
+114,245
New +$51.8M 0.11% 180

Other funds holding SGTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Canada Pension Plan Investment Board's SGTX Position: Q3 2023 in Review

Canada Pension Plan Investment Board sold out of Sigilon Therapeutics, Inc. Common Stock (SGTX) in Q3 2023, closing a stake of 114,244 shares — an estimated $2.57M sold.

Canada Pension Plan Investment Board first reported a position in SGTX in Q4 2020 and held it in 11 quarters. The position peaked at $71.3M in Q4 2020. 1 fund tracked by Wall St. Rank holds SGTX as of Q3 2023.

  • Canada Pension Plan Investment Board reported no remaining Sigilon Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 114,244 Sigilon Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2.57M.
  • Canada Pension Plan Investment Board first reported a position in Sigilon Therapeutics, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • Canada Pension Plan Investment Board's Sigilon Therapeutics, Inc. Common Stock position peaked at $71.3M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Sigilon Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2023, filed 9 Nov 2023.